As of December 31, 2025, Proteome Sciences PLC carries a market capitalization of 11.25M, placing it among publicly traded companies globally. Its enterprise value stands at 31.45M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 11.25M |
| Enterprise Value | 31.45M |
As of December 31, 2025, Proteome Sciences PLC has 295.18M shares outstanding.
| Shares Outstanding | 295.18M |
These figures are as of December 31, 2025.
| PB Ratio | -0.88 |
| P/TBV Ratio | -0.61 |
As of December 31, 2025, Proteome Sciences PLC maintains a current ratio of 0.13, meaning it holds 0.1x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.13 |
| Quick Ratio | 0.05 |
| Debt / Equity | -165.46 |
These figures cover the twelve months ended December 31, 2025.
| Employee Count | 34.00 |
As of the close on September 2, 2026, Proteome Sciences PLC's stock has declined approximately 75.06% over the past 52 weeks.
| 52-Week Price Change | -75.06% |
| 50-Day Moving Average | 0.04 |
As of December 31, 2025, Proteome Sciences PLC holds 1.05M in cash and equivalents against 21.25M in total debt, resulting in a net debt position of 18.43M. Total book value stands at -12.84M, with working capital of -19.53M providing operational flexibility.
| Cash & Cash Equivalents | 1.05M |
| Total Debt | 21.25M |
| Net Debt | 18.43M |
| Equity (Book Value) | -12.84M |
| Book Value Per Share | -0.04 |
| Working Capital | -19.53M |
Proteome Sciences PLC's most recent stock split took place on June 11, 2010.
| Last Split Date | 6/11/2010 |
Already premium?